Pay in 4 interest-free payments of $6.86 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Individuals using GLP-1s for diabetes experienced a six percentage point improvement in medical spend growth compared to the control group between 12 months and 30 months post GLP-1s initiation
Lilly releases Zepbound (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity Distributed through LillyDirect 's self-pay channel, Zepbound single-dose vials are at least 50% less than the list price of all other incretin medicines for obesity (tirzepatide) 2.5 mg and 5 mg single-dose vials are available for self-pay for patients with an on-label prescription, significantly expanding the supply of Zepbound in response to high demand
GHK-Cu amplifies results through collagen gene upregulation, making this combination highly relevant for joint and tendon repair research
Some patients use it twice daily depending on their goals
